Condition: Granulocyte Colony-stimulating Factor · Biliary Atresia · Sponsor: National Liver Institute, Egypt
The aim of the study is to evaluate the use of Granulocyte Colony Stimulating Factor (GCSF) on the clinical and biochemical outcome of type 3 biliary atresia post kasai.
This description comes directly from the study's public registry record.
Marwa Narwa Foad Asker, master · +201008913103 · marwafoadali@gmail.com
Behairy Behairy El Sayed Behairy, MD · +201001847754 · behairyelsayed@yahoo.com
Always discuss trial participation with your own doctor first.
| National Liver Institute | Cairo, Menofia Governorate, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06708572